Formulation containing tiotropium Powder for Inhalation

摘要

Powdery formulations containing tiotropium inhalation for the procedures for their production, and their use for the preparation of a Medicament for the treatment of respiratory diseases, particularly for the treatment of COPD (Chronic Obstructive pulmonary disease, chronic lung disease obstructuva =) and Asthma.Claim 1: Powder for Inhalation containing 0.001 to 3 per cent of tiotropium in physiologically harmless substance mixed with an adjuvant, wherein the adjuvant substance has an average particle size of 10 - 50 microns, a fine of 10% portion of 0.5 to 6 microns And a specific surface area of 0.1 to 2 m2 / G.Claim: 6 capsules containing an inhalation Powder according to one of claims 1 to 4. Box 10: Claim for Inhalation comprising a Capsule with an agreement of Claims 6 to 9 and an Inhaler, which can be used for the application of Powders for Inhalation from Capsules containing Powders.Box 11: Claim for Inhalation according to claim 10, wherein the Inhaler is characterized by a type 1, which contains two Windows Cover 2, a 3, in which there are holes for the Air Inlet and is provided with a Sieve 5 fixed on a Housing 4 Sieve, a camera connected with the indoor inhalation for 6 3The next scheduled trigger a Sharp 7 9 with two Needles, which is movable against spring 8, a 12 bit United Way Through a hinged Shaft 10 accommodation with 1, 3 and a COVER CAP Holes 11 and 13 for the passage of air to adjust The Resistance to Movement.